Correlation Engine 2.0
Clear Search sequence regions


  • humans (1)
  • patients (6)
  • pneumonia (6)
  • risk factors (3)
  • Sizes of these terms reflect their relevance to your search.

    The goal of our study was to discover and analyze possible risk factors for and possible protective factors against the occurrence of potential drug-drug interactions (pDDIs) in a hospitalized patient with community-acquired pneumonia. The central outcome was the incidence of pDDIs in patients with community-acquired pneumonia checked by Lexicomp and Micromedex interaction checkers. The most severe pDDIs (Consider therapy modification D/Avoid combination X/Major/Contraindicated) were found in 19 (20%) and 54 (58%) patients, according to Lexicomp and Micromedex, respectively. Patients with community-acquired pneumonia who were older, smokers, and with more prescribed drugs by more than a few independent prescribers had a higher risk to experience pDDIs. Possible protective factors were longer length of hospitalization, transfer from the Emergency Department, antiarrhythmic drugs as well as an anticoagulant therapy. In conclusion, community-acquired pneumonia patients with the above-mentioned factors should have their treatment more deeply monitored for pDDIs.

    Citation

    Slobodan Jankovic, Radica Zivkovic Zaric, Milorad Stojadinovic, Zorica Lazic, Ivan Cekerevac, Romana Susa. Risk factors for potential drug-drug interactions in patients with pneumonia. International journal of clinical pharmacology and therapeutics. 2021 Jan;59(1):42-46

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32990216

    View Full Text